Department of Health and Social Care | pharmaphorum

Skip to main content

Saturday 2 November 2024

twitter linkedin facebook rss

User account menu

Subscribe

Channels

Content type

Categories

Categories

Sort by

Order

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

close

Channels

Content type

Categories

Categories

Sort by

Order

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

Sign up

twitter linkedin facebook rss

Sign in

Department of Health and Social Care

News

UK Health Secretary Victoria Atkins

Victoria Atkins replaces Barclay as UK Health Secretary

Victoria Atkins is replacing Steve Barclay as Secretary of State for Health and Social Care in a reshuffle that claimed the job of home secretary Suella Braverman and saw

Market Access

medicine innovation

England’s Innovative Medicines Fund hits another milestone

Leela Barham takes a look at the latest milestone on what will have been a close to three-year journey to an Innovative Medicines Fund (IMF) in England.

Views & Analysis

Achievement so far on objectives for the economy and innovation

VPAS: Achievement so far on objectives for the economy and i...

In the third part of this series taking stock of

Market Access

Jeremy Hunt NHS Department of Health

Matt Hancock has big shoes to fill as he takes over from Jer...

What changes will the appointment of Matt Hancock MP as Secretary of State for Health and Social Care mean for the NHS?

Editor's Picks

Lundbeck planning for four novel drugs in phase 3 in 2026

MSD buys Modifi for $1.3bn to boost oncology pipeline

GSK plans $800m US manufacturing investment

Seaport docks $225m for its improved neuropsychiatry drugs

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

News

Lexicon's type 1 diabetes drug voted down by FDA adcomm

Lexicon's type 1 diabetes drug voted down by FDA adcomm

It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Needle with colourful threads

Sponsored

Global reach, personal touch: Mastering customer engagement ...

In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Subscribe

rss facebook linkedin twitter

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2024, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company